Genesis Therapeutics Company
GEMS AI platform combines physics and deep learning to accelerate the discovery of novel small molecule drugs.
Investors
Connections from
Founded Date:
2019
Total Funding:
$280M
Headquarters:
USA
Industry:
Early Drug Development